Quizartinib inhibits necroptosis by targeting receptor‐interacting serine/threonine protein kinase 1
Article in The FASEB Journal (September 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
Article in Cancer Medicine (January 2023)
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
Preprint in Research Square (June 2022)